“KLF7 Overexpression in Colon Adenocarcinoma Associated with Poor Prognosis and Tumor Progression: A Potential Biomarker and Therapeutic Target”

https://pubmed.ncbi.nlm.nih.gov/38116138

The abstract suggests that KLF7, a transcription factor, is overexpressed in colon adenocarcinoma, associated with advanced stage and poor prognosis, and promoting tumor growth and metastasis, suggesting its potential as a prognostic biomarker and therapeutic target.